Literature DB >> 17419722

National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.

E Mannucci1, M Monami, B Cresci, L Pala, G Bardini, M G Petracca, I Dicembrini, A Pasqua, E Buiatti, C M Rotella.   

Abstract

BACKGROUND: The International Diabetes Federation (IDF) proposed to modify the diagnostic criteria for metabolic syndrome (MS) previously issued by the National Cholesterol Education Program (NCEP). Aim of the present investigation is to compare the predictive value for diabetes of NCEP and IDF definitions of MS in a large sample of predominantly Caucasian subjects.
METHODS: A prospective observational study was performed on a cohort study (n = 3096) enrolled in a diabetes-screening programme, the FIrenze-Bagno A Ripoli study. All subjects with fasting glucose >126 mg/dl and/or post-load glucose > or =200 mg/dl (5.7%) were excluded from the present analysis. Follow-up of each subject was continued until diagnosis of diabetes, death or until 31 December 2005. Mean follow-up was 27.7 +/- 11.3 months.
RESULTS: Among subjects enrolled, 13.7 and 25.2% were affected by MS using NCEP and IDF criteria respectively. During follow-up, 38 new cases of diabetes were diagnosed, with a yearly incidence rate of 0.5%. The relative risk for diabetes in subjects with MS was 10.10 [5.13; 20.00] and 7.87 [3.70; 16.7] using NCEP and IDF definitions respectively. After adjustment for age, sex, fasting glucose and waist circumference, NCEP-defined MS, but not IDF-, was significantly associated with incident diabetes (hazard ratio, 95% CI: 2.41 [1.01; 5.95] and 2.05 [0.80; 5.29] respectively).
CONCLUSIONS: Although the reasons for the proposed changes in diagnostic criteria for MS are easily understandable, the newer IDF definition, while increasing estimates of prevalence of the syndrome, reduces the effectiveness of MS in identifying subjects at risk for diabetes. Further research is needed before the previous NCEP criteria are abandoned.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17419722     DOI: 10.1111/j.1463-1326.2007.00724.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  8 in total

Review 1.  Cardiovascular risk in the metabolic syndrome: fact or fiction?

Authors:  Peter M Nilsson
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

2.  The concomitant use of second-generation antipsychotics and long-term antiretroviral therapy may be associated with increased cardiovascular risk.

Authors:  Maria Ferrara; Anya Umlauf; Chelsea Sanders; Jonathan M Meyer; John Allen McCutchan; Nichole Duarte; Joseph Hampton Atkinson; Igor Grant; Ronald J Ellis
Journal:  Psychiatry Res       Date:  2014-04-18       Impact factor: 3.222

3.  Mind the mortality gap: the importance of metabolic function in mental illnesses.

Authors:  Oliver D Howes; Katherine Beck
Journal:  Psychopharmacology (Berl)       Date:  2013-11       Impact factor: 4.530

4.  The metabolic syndrome and risk of chronic kidney disease: pathophysiology and intervention strategies.

Authors:  Heather A Laguardia; L Lee Hamm; Jing Chen
Journal:  J Nutr Metab       Date:  2012-02-22

5.  Impact of metabolic syndrome compared with impaired fasting glucose on the development of type 2 diabetes in a general Japanese population: the Hisayama study.

Authors:  Naoko Mukai; Yasufumi Doi; Toshiharu Ninomiya; Jun Hata; Koji Yonemoto; Masanori Iwase; Mitsuo Iida; Yutaka Kiyohara
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

6.  Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.

Authors:  Earl S Ford; Matthias B Schulze; Tobias Pischon; Manuela M Bergmann; Hans-Georg Joost; Heiner Boeing
Journal:  Cardiovasc Diabetol       Date:  2008-12-12       Impact factor: 9.951

Review 7.  Metabolic syndrome and incident diabetes: current state of the evidence.

Authors:  Earl S Ford; Chaoyang Li; Naveed Sattar
Journal:  Diabetes Care       Date:  2008-06-30       Impact factor: 19.112

8.  Regardless of central obesity, metabolic syndrome is a significant predictor of type 2 diabetes in Japanese Americans.

Authors:  Yu Sakashita; Shuhei Nakanishi; Masayasu Yoneda; Reiko Nakashima; Kiminori Yamane; Nobuoki Kohno
Journal:  J Diabetes Investig       Date:  2015-02-13       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.